Substrate | Km | Vmax | Vmax/Km |
---|---|---|---|
mM | μmol · mg-1 · min-1 | ml · mg-1 · min-1 | |
N-Acetyl-l-tyrosine | 1.4 ± 0.32 | 7.5 ± 1.1 | 5.4 |
N-Acetyl-l-phenylanine | 1.6 ± 0.45 | 7.9 ± 1.2 | 4.9 |
N-Acetyl-l-tryptophan | 1.2 ± 0.50 | 8.1 ± 1.5 | 6.8 |
N-Acetyl-l-histidine | 1.8 ± 0.23 | 5.9 ± 1.0 | 3.3 |
N-Acetyl-l-cysteine | 0 | ||
N-Acetyl-l-aspartic acid | 0 | ||
Nα-Acetyl-l-lysine | 1.3 ± 0.21 | 5.8 ± 0.80 | 4.5 |
Nϵ-Acetyl-l-lysine | 0 | ||
N-Acetyl-S-benzyl-l-cysteine | 1.1 ± 0.11 | 11.7 ± 1.4 | 10.6 |
N-Acetyl-S-(2-fluorobenzyl)-l-cysteine | 1.3 ± 0.22 | 4.8 ± 0.90 | 3.7 |
N-Acetyl-S-(2-chlorobenzyl)-l-cysteine | 1.45 ± 0.46 | 12.1 ± 1.5 | 8.3 |
N-Acetyl-S-(3-fluorobenzyl)-l-cysteine | 0.6 ± 0.25 | 3.5 ± 0.70 | 5.8 |
N-Acetyl-S-(4-chlorobenzyl)-l-cysteine | 0.3 ± 0.05 | 10.6 ± 1.2 | 35.3 |
N-Acetyl-S-(4-bromobenzyl)-l-cysteine | 0.5 ± 0.10 | 16.1 ± 3.2 | 32.2 |
N-Acetyl-S-(4-methoxybenzyl)-l-cysteine | 0.8 ± 0.12 | 5.5 ± 0.90 | 6.9 |
N-Acetyl-S-(1,1,2,2-tetrafluoroethyl)-l-cysteine | 0.25 ± 0.10 | 0.81 ± 0.23 | 3.2 |
N-Acetyl-S-(2-chloro-1,1,2-trifluoroethyl)-l-cysteine | 0.28 ± 0.12 | 0.56 ± 0.29 | 2.0 |
N-Acetyl-S-(2,2-difluoro-1,1-dichloroethyl)-l-cysteine | 0.3 ± 0.09 | 1.1 ± 0.40 | 3.7 |
N-Acetyl-S-(2,2-dichloro-1,1-difluoroethyl)-l-cysteine | 5.3 ± 0.12 | 32.1 ± 3.1 | 10.4 |
N-Acetyl-S-(1,2,2-trichlorovinyl)-l-cysteine | 1.2 ± 0.22 | 24.0 ± 1.9 | 20 |
N-Acetyl-S-(1,2-dichlorovinyl)-l-cysteine | 0.9 ± 0.07 | 15.7 ± 1.8 | 17.4 |
N-Acetyl-S-(2,2-dichlorovinyl)-l-cysteine | 0.4 ± 0.11 | 21.8 ± 2.9 | 54.5 |
N-Acetyl-S-(1,2,3,4,4-pentachlorobutadienyl)-l-cysteine | 1.0 ± 0.23 | 25.3 ± 4.4 | 25.3 |